ImmuCell Corp. Company Profile (NASDAQ:ICCC)

About ImmuCell Corp.

ImmuCell Corp. logoImmuCell Corporation is an animal health company. The Company operates in the development, acquisition, manufacture and sale of products that improve the health and productivity of cows for the dairy and beef industries segment. The Company has developed products that provide immediate immunity to newborn dairy and beef cattle, and is developing product line extensions of its existing products that address mastitis. The Company's lead product, First Defense, is manufactured from cows' colostrum utilizing its vaccine and milk protein purification technologies. Its Wipe Out Dairy Wipes are made from a non-woven fabric that allows for a vigorous cleaning. It also developed California Mastitis Test (CMT), which is used for bulk tank, as well as individual cow sample monitoring and is used to determine which quarter of the udder is mastitic. Its product development initiative is Mast Out, a Nisin-based intramammary treatment of subclinical mastitis in lactating dairy cows.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: ICCC
  • CUSIP:
Key Metrics:
  • Previous Close: $7.20
  • 50 Day Moving Average: $7.1483
  • 200 Day Moving Average: $6.7216
  • Trailing P/E Ratio: 24.4628
  • P/E Growth: 0.0000
  • Market Cap: $30.46M
  • Outstanding Shares: 4,179,000
  • Beta: 0.7
Additional Links:
Companies Related to ImmuCell Corp.:

Analyst Ratings

Consensus Ratings for ImmuCell Corp. (NASDAQ:ICCC) (?)
Ratings Breakdown: No ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Consensus Price Target: N/A

Analysts' Ratings History for ImmuCell Corp. (NASDAQ:ICCC)
Show:
No equities research coverage for this company has been tracked by MarketBeat.com

Earnings

Earnings History for ImmuCell Corp. (NASDAQ:ICCC)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/10/2016        
5/11/2016Q1$0.11$2.99 millionViewN/AView Earnings Details
2/10/2016Q315$0.09$2.21 million$2.70 millionViewListenView Earnings Details
2/11/2015Q414$0.04$1.56 million$2.21 millionViewN/AView Earnings Details
8/12/2014Q214($0.10)$1.37 million$1.54 millionViewN/AView Earnings Details
2/13/2014Q413($0.05)$1.42 million$1.56 millionViewN/AView Earnings Details
11/12/2013Q313$0.02$1.08 million$1.24 millionViewN/AView Earnings Details
11/7/2012Q312($0.02)$1.00 million$1.08 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for ImmuCell Corp. (NASDAQ:ICCC)
No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for ImmuCell Corp. (NASDAQ:ICCC)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for ImmuCell Corp. (NASDAQ:ICCC)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
7/8/2016Joseph H CrabbVPSell1,935$6.55$12,674.25View SEC Filing  
7/7/2016Joseph H CrabbVPSell2,691$6.58$17,706.78View SEC Filing  
7/5/2016Joseph H CrabbVPSell5,374$6.74$36,220.76View SEC Filing  
3/21/2016David Scott TomscheDirectorBuy955$6.67$6,369.85View SEC Filing  
1/29/2016David CunninghamDirectorBuy1,904$5.25$9,996.00View SEC Filing  
9/3/2015Jonathan E. RothschildDirectorBuy3,000$6.63$19,890.00View SEC Filing  
9/1/2015David Scott TomscheDirectorBuy1,000$6.73$6,730.00View SEC Filing  
8/31/2015Jonathan E. RothschildDirectorBuy6,100$7.37$44,957.00View SEC Filing  
8/28/2015David Scott TomscheDirectorBuy1,500$7.27$10,905.00View SEC Filing  
11/26/2014Jonathan E RothschildDirectorBuy2,100$4.82$10,122.00View SEC Filing  
8/20/2014Jonathan E RothschildDirectorBuy3,000$4.55$13,650.00View SEC Filing  
6/16/2014Jonathan E RothschildDirectorBuy5,901$4.57$26,967.57View SEC Filing  
5/15/2014David CunninghamDirectorBuy1,500$3.91$5,865.00View SEC Filing  
8/23/2013Jonathan E RothschildDirectorBuy1,500$3.98$5,970.00View SEC Filing  
8/16/2013David CunninghamDirectorBuy4,000$3.68$14,720.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for ImmuCell Corp. (NASDAQ:ICCC)
DateHeadline
News IconImmuCell records loss despite increase in sales (NASDAQ:ICCC)
www.mainebiz.biz - August 16 at 5:44 PM
capitalcube.com logoImmuCell Corp. :ICCC-US: Earnings Analysis: Q2, 2016 By the Numbers : August 15, 2016 (NASDAQ:ICCC)
www.capitalcube.com - August 15 at 5:47 PM
News IconImmuCell reports 21 percent sales increase in second quarter (NASDAQ:ICCC)
www.pressherald.com - August 13 at 8:31 AM
finanznachrichten.de logoImmuCell Announces Second Quarter 2016 Financial Results (NASDAQ:ICCC)
www.finanznachrichten.de - August 13 at 8:31 AM
seekingalpha.com logoImmuCell's (ICCC) CEO Michael Brigham on Q2 2016 Results - Earnings Call Transcript (NASDAQ:ICCC)
seekingalpha.com - August 13 at 8:31 AM
streetinsider.com logoImmucell Corp (ICCC) Reports Q2 EPS of $0.00 (NASDAQ:ICCC)
www.streetinsider.com - August 13 at 8:31 AM
publicnow.com logo08-11-2016 ImmuCell Announces Second Quarter 2016 Financial Results (NASDAQ:ICCC)
www.publicnow.com - August 11 at 5:48 PM
biz.yahoo.com logoQ2 2016 ImmuCell Corp Earnings Release - After Market Close (NASDAQ:ICCC)
biz.yahoo.com - August 11 at 8:36 AM
publicnow.com logo08-03-2016 “ImmuCell to Announce Second Quarter 2016 Financial Results (NASDAQ:ICCC)
www.publicnow.com - August 4 at 5:53 PM
finance.yahoo.com logoImmuCell to Announce Second Quarter 2016 Financial Results (NASDAQ:ICCC)
finance.yahoo.com - August 3 at 5:52 PM
News IconVP & Chief Scientific Officer of ImmuCell Corporation (NASDAQ:ICCC), Crabb Joseph H, sells 1,935 shares worth $12,669 (NASDAQ:ICCC)
empowerednews.net - July 12 at 5:51 PM
News IconImmuCell looks to tax break to aid in Portland expansion (NASDAQ:ICCC)
www.mainebiz.biz - July 6 at 10:15 AM
biz.yahoo.com logoIMMUCELL CORP /DE/ Files SEC form 8-K/A, Submission of Matters to a Vote of Security Holders, Financial Statements an (NASDAQ:ICCC)
biz.yahoo.com - June 16 at 3:35 PM
biz.yahoo.com logoIMMUCELL CORP /DE/ Files SEC form 8-K, Submission of Matters to a Vote of Security Holders (NASDAQ:ICCC)
biz.yahoo.com - June 15 at 4:47 PM
biz.yahoo.com logoIMMUCELL CORP /DE/ Files SEC form 8-K, Changes in Registrant's Certifying Accountant (NASDAQ:ICCC)
biz.yahoo.com - May 23 at 10:10 AM
capitalcube.com logoImmuCell Corp. :ICCC-US: Earnings Analysis: Q1, 2016 By the Numbers (NASDAQ:ICCC)
www.capitalcube.com - May 17 at 2:58 PM
publicnow.com logo5-11-2016 “ImmuCell to Announce First Quarter 2016 Financial Results: (NASDAQ:ICCC)
www.publicnow.com - May 11 at 5:07 PM
biz.yahoo.com logoIMMUCELL CORP /DE/ Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibi (NASDAQ:ICCC)
biz.yahoo.com - May 11 at 4:33 PM
finance.yahoo.com logoImmuCell Announces First Quarter 2016 Financial Results (NASDAQ:ICCC)
finance.yahoo.com - May 11 at 4:16 PM
biz.yahoo.com logoIMMUCELL CORP /DE/ Files SEC form 10-Q, Quarterly Report (NASDAQ:ICCC)
biz.yahoo.com - May 11 at 4:10 PM
biz.yahoo.com logoQ1 2016 ImmuCell Corp Earnings Release - After Market Close (NASDAQ:ICCC)
biz.yahoo.com - May 11 at 7:07 AM
publicnow.com logo5-4-2016 “ImmuCell to Announce First Quarter 2016 Financial Results” (NASDAQ:ICCC)
www.publicnow.com - May 4 at 5:11 PM
finance.yahoo.com logoImmuCell to Announce First Quarter 2016 Financial Results (NASDAQ:ICCC)
finance.yahoo.com - May 4 at 1:14 PM
publicnow.com logo4-4-2016 “Immucell Appoints Elizabeth Williams Vice President of Manufacturing Operations (NASDAQ:ICCC)
www.publicnow.com - April 5 at 11:02 AM
finance.yahoo.com logoImmuCell Appoints Elizabeth Williams Vice President of Manufacturing Operations (NASDAQ:ICCC)
finance.yahoo.com - April 4 at 5:40 PM
biz.yahoo.com logoIMMUCELL CORP /DE/ Files SEC form 8-K, Creation of a Direct Financial Obligation or an Obligation under an Off-Balanc (NASDAQ:ICCC)
biz.yahoo.com - March 31 at 5:07 PM
biz.yahoo.com logoIMMUCELL CORP /DE/ Files SEC form 10-K, Annual Report (NASDAQ:ICCC)
biz.yahoo.com - March 25 at 9:17 AM
biz.yahoo.com logoIMMUCELL CORP /DE/ Files SEC form 8-K, Changes in Registrant's Certifying Accountant, Financial Statements and Exhibi (NASDAQ:ICCC)
biz.yahoo.com - March 7 at 3:56 PM
capitalcube.com logoImmuCell Corp. Earnings Analysis: 2015 By the Numbers (NASDAQ:ICCC)
www.capitalcube.com - February 16 at 1:03 PM
finance.yahoo.com logoImmuCell Announces Full Year 2015 Financial Results (NASDAQ:ICCC)
finance.yahoo.com - February 10 at 4:05 PM
biz.yahoo.com logoQ4 2015 ImmuCell Corp Earnings Release - After Market Close (NASDAQ:ICCC)
biz.yahoo.com - February 10 at 7:07 AM
finance.yahoo.com logoImmuCell to Announce 2015 Financial Results (NASDAQ:ICCC)
finance.yahoo.com - February 4 at 8:00 AM
biz.yahoo.com logoIMMUCELL CORP /DE/ Files SEC form 8-K, Other Events (NASDAQ:ICCC)
biz.yahoo.com - February 3 at 10:47 AM
finance.yahoo.com logoImmuCell Corporation Announces Closing of $5.9 Million Public Offering of Common Stock (NASDAQ:ICCC)
finance.yahoo.com - February 3 at 10:45 AM
publicnow.com logo1-28-2016 “ImmuCell Corporation Announces Proposed Public Offering” (NASDAQ:ICCC)
www.publicnow.com - January 29 at 5:32 PM
publicnow.com logo1-29-2016 “1ImmuCell Corporation Announces Pricing of $5.9 million Public Offering of Common Shares” (NASDAQ:ICCC)
www.publicnow.com - January 29 at 5:02 PM
biz.yahoo.com logoIMMUCELL CORP /DE/ Files SEC form 8-K, Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financia (NASDAQ:ICCC)
biz.yahoo.com - January 29 at 3:25 PM
nasdaq.com logoMid-Day ETF Update: ETFs, Stocks Hold on to Gains as BOJ Rate Cut Eclipses Mixed Economic Data (NASDAQ:ICCC)
www.nasdaq.com - January 29 at 2:42 PM
finance.yahoo.com logo7:31 am ImmuCell Corporation prices ~1.1 mln common stock offering at $5.25/share for net proceeds of ~$5.3 mln (NASDAQ:ICCC)
finance.yahoo.com - January 29 at 7:31 AM
finance.yahoo.com logoImmuCell Corporation Announces Pricing of $5.9 Million Public Offering of Common Shares (NASDAQ:ICCC)
finance.yahoo.com - January 29 at 7:30 AM
finance.yahoo.com logoImmuCell Corporation Announces Proposed Public Offering of Common Stock and Preliminary Full Year 2015 Results (NASDAQ:ICCC)
finance.yahoo.com - January 28 at 5:52 PM
finance.yahoo.com logoImmuCell Acquires Certain Assets From Minnesota Firm (NASDAQ:ICCC)
finance.yahoo.com - January 6 at 8:00 AM
noodls.com logo12-22-2015 “ImmuCell Enters into New Contract with Norbrook” (NASDAQ:ICCC)
www.noodls.com - December 22 at 10:34 AM
finance.yahoo.com logoImmuCell Enters Into New Contract With Norbrook (NASDAQ:ICCC)
finance.yahoo.com - December 22 at 8:00 AM
finance.yahoo.com logoIMMUCELL CORP /DE/ Financials (NASDAQ:ICCC)
finance.yahoo.com - December 8 at 1:18 PM
capitalcube.com logoImmuCell Corp. Earnings Analysis: Q3, 2015 By the Numbers (NASDAQ:ICCC)
www.capitalcube.com - December 8 at 11:40 AM
biz.yahoo.com logoIMMUCELL CORP /DE/ Files SEC form 8-K, Results of Operations and Financial Condition (NASDAQ:ICCC)
biz.yahoo.com - November 12 at 4:08 PM
finance.yahoo.com logoImmuCell Announces Results for Third Quarter of 2015 (NASDAQ:ICCC)
finance.yahoo.com - November 12 at 4:05 PM
biz.yahoo.com logoQ3 2015 ImmuCell Corp Earnings Release - After Market Close (NASDAQ:ICCC)
biz.yahoo.com - November 12 at 7:07 AM
noodls.com logo11-5-2015 “ImmuCell to Announce Third Quarter 2015 Financial Results” (NASDAQ:ICCC)
www.noodls.com - November 10 at 3:46 PM

Social

ImmuCell Corp. (NASDAQ:ICCC) Chart for Friday, August, 26, 2016


Last Updated on 8/26/2016 by MarketBeat.com Staff